Rockwell Medical Inc. (RMTI) Fundamentals

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States.
SHARE INFORMATION
Market Cap$ 17,771,986
Shares Outstanding8,544,224
Float7,064,619
Percent Float82.68%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 61,930,000
Latest Fiscal EPS$ -3.74
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions148
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months1,166,295
Institutional Holdings Percent28.2%
Institutional Sold Previous 3 Months6,380,460
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent7.5
Insider Sold Previous 3 Months-
Insider Shares Owned7,031,780
TRADING INFO
52 Week High$ 11.66
52 Week Low$ 1.87
52 Week High Change$ -79.75
21 Day Moving Average$ 3.3685
21 Day Extended Moving Average$ 3.1419
50 Day Moving Average$ 3.9231
50 Day Extended Moving Average$ 3.6554
200 Day Moving Average$ 5.1077
200 Day Extended Moving Average$ 5.5152
10 Day Average Volume102,960
20 Day Average Volume59,957
30 Day Average Volume54,490
50 Day Average Volume52,038
Alpha-0.048666
Beta1.0882
Standard Deviation0.180352
R20.081573
7 Day Price Change$ -1.11
7 Day Percent Change-34.8%
21 Day Price Change$ -1.56
21 Day Percent Change-42.91%
30 Day Price Change$ -2.09
30 Day Percent Change-50.15%
Month to Date Price Change$ -1.53
Month to Date Percent Change-42.35%
Quarter to Date Price Change$ -3.10
Quarter to Date Percent Change-59.88%
180 Day Price Change$ -3.93
180 Day Percent Change-65.39%
200 Day Price Change$ -3.82
200 Day Percent Change-64.75%
Year to Date Price Change$ -2.43
Year to Date Percent Change-53.88%

Rockwell Medical Inc. (RMTI) Key Ratios

PROFITABILITY
EBIT Margin-48.9%
EBITDA Margin-44.9%
Pre-Tax Profit Margin-51.9%
Profit Margin Count-53.61%
Gross Margin-3.9%
Profit Margin TOT-53.61%
INCOME STATEMENTS
Revenue$ 46,458,000
Revenue Per Share$ 0.4943
Revenue (3 Years)$ -0.84
Revenue (5 Years)$ 2.53
FINANCIAL STRENGTH
Price to Tangible Book10.80
Total Debt To Equity11.40
Int Coverage-12.80
Current Ratio1.70
Leverage Ratio5.50
Quick Ratio1.40
Long Term Debt To Capital0.88
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 23,887,216
Price to Sales4.2079
Price to Free Cash-0.80
PE High Last 5 Years-4.80
Price To Book6.90
Price To Cash Flow76.10
PE Low Last 5 Years-12.70
Price to Tangible Book10.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover9.60
Invoice Turnover16.00
Assets Turnover0.80
Return Assets-54.03
Return on Equity-190.27
Return on Capital-67.76

Rockwell Medical Inc. (RMTI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEORussell H. Ellison
Emplyoees300
Last AuditUQ
CIK0001041024
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address30142 S. Wixom Road
Suite 501
Wixom, MI 48393
Websitehttps://www.rockwellmed.com
Facsimile+1 248 960-9119
Telephone+1 248 960-9009
Emailinvest@rockwellmed.com
Your Recent History
NASDAQ
RMTI
Rockwell M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220518 09:20:55